Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2633]

ASCO 2015: Nivolumab extends survival for patients with the most common lung cancer

ASCO 2015: Nivolumab extends survival for patients with the most common lung cancer

ASCO 2015: Genomic marker predicts anti-PD-1 response in several cancers

ASCO 2015: Genomic marker predicts anti-PD-1 response in several cancers

Lower cancer survival in UK linked to delays in referring patients for tests

Lower cancer survival in UK linked to delays in referring patients for tests

Next generation sequencing-based tumour genomic profiling aids in detecting hereditary variants in cancer risk genes

Next generation sequencing-based tumour genomic profiling aids in detecting hereditary variants in cancer risk...

Scientists discover new molecules that kill cancer cells and protect healthy cells

Scientists discover new molecules that kill cancer cells and protect healthy cells

EU consortium validates blood-based cancer biomarkers

EU consortium validates blood-based cancer biomarkers

Multiple types of resistance to new lung cancer drug identified

Multiple types of resistance to new lung cancer drug identified

Prolonged statin use may lower risk of lung cancer death

Prolonged statin use may lower risk of lung cancer death

New studies examine the significant risk of life-threatening blood clots in post-surgical lung cancer patients

New studies examine the significant risk of life-threatening blood clots in post-surgical lung cancer patients

New proton therapy technique brings hope of more effective treatment for tumours without causing collateral damage

New proton therapy technique brings hope of more effective treatment for tumours without causing collateral damage

More from ecancer